LABCORP EXPANDS DRUG DEVELOPMENT SOLUTIONS WITH ACQUISITION OF SCIFORMIX
Sciformix extends Covance’s pharmacovigilance capabilities for post-approval safety solutions
LabCorp® (NYSE: LH), a leading global life sciences company, announced ...




















